The results of trans-well assays show that miR-210 promotes osteosarcoma cell migration and invasion, while FGFRL1 overexpression deprives the promotion effect of miR-210 on cell migration and invasion [96]. The gene discussed is FGFRL1; the disease is osteosarcoma.